Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Chad, 2013.
Emerg Infect Dis
; 21(1): 115-8, 2015 Jan.
Article
em En
| MEDLINE
| ID: mdl-25536336
In 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated areas, but an epidemic continued in the rest of Chad. In 2012, the remaining Chad population was vaccinated, and the epidemic was halted.
Texto completo:
1
Coleções:
01-internacional
Contexto em Saúde:
2_ODS3
/
4_TD
Base de dados:
MEDLINE
Assunto principal:
Vacinação
/
Vacinas Meningocócicas
/
Meningite Meningocócica
Limite:
Adolescent
/
Adult
/
Child
/
Child, preschool
/
Humans
/
Infant
País/Região como assunto:
Africa
Idioma:
En
Revista:
Emerg Infect Dis
Ano de publicação:
2015
Tipo de documento:
Article